The CJC-1295 File: Who’s Actually Signing for What They Sell You

I got asked where to buy CJC-1295 by three different people this month. Same question, same tone, like they already knew the answer wouldn’t be simple. It isn’t. So I went and pulled the paper.

Here’s the state of the evidence, up front, no dressing: CJC-1295 has never been approved by the FDA. The human file on it is thin: one pharmacology study, and one late-stage trial that got shut down after somebody died on it. Every number I use below traces back to a source in the list at the bottom. Check my work. That’s the point of listing it.

The setup

Ask around online for CJC-1295 and you’ll land on a dozen storefronts inside five minutes. Most of them have the same three things: a shopping cart, a vial, and a sticker reading “research use only.” That sticker isn’t a warning label. It’s a legal alibi. It’s the sentence that keeps the seller out of court while you take on every ounce of the risk.

So before I ranked anybody, I asked one question and refused to move on until I had an answer: is there a licensed clinician anywhere in this transaction, or is it just a warehouse and a wish?

That single answer sorts this whole list into two tiers. Everything else is detail.

TL;DR

• The safer route to CJC-1295 runs through a licensed telehealth outfit: a clinician evaluates you, a prescription gets written if it’s warranted, a licensed pharmacy compounds and dispenses the thing. FormBlends is my #1 for exactly that reason. HealthRX (healthrx.com) sits at #2, running the same clinician-first, pharmacy-dispensed setup.
• Supervised CJC-1295 costs roughly $150 to $300 a month. The longer-acting DAC version runs roughly $80 to $200. Same molecules the gray market mails you with nobody watching.
• The research-chemical names you keep finding, Amino Asylum, Sports Technology Labs, Biotech Peptides, Pure Rawz, Limitless Life, sit below the line. Vials shipped labeled “not for human use.” No clinician. No prescription. No follow-up call to see if you’re okay.
• Be straight with yourself about the compound itself. One small human study. No real outcome data. No FDA approval. And a trial that got halted after a participant died. A provider’s job here is oversight and honesty, not a guarantee the peptide is proven.

The rubric: who’s accountable when this goes wrong

I’m not in the business of talking people out of an interest in CJC-1295. I’m in the business of finding out who answers for what’s in the vial. Five questions, all pointing at the same idea.

1. Does a clinician see you first? Someone licensed, reviewing your history and your other medications before you inject something that moves your growth hormone axis. Heaviest weight on the sheet.
2. Does a licensed pharmacy make it and hand it over? That’s the line between sterility and identity built into the process, versus taking a chemical retailer’s word for it.
3. Does the source tell you the truth about the evidence? One study. A safety event in the file. No FDA approval. Or does it dress the compound up as settled science?
4. Is there a real regulatory floor under this? A recognized telehealth-and-pharmacy structure, or a “research use only” sticker doing legal cover work?
5. Is the label honest? Compounded medication called what it is, or an unapproved chemical wearing a supplement costume?

Price isn’t on this list. Cheap doesn’t mean safe. On this list, cheap usually means nobody’s name is attached to the outcome.

The ranking

Rank	Source	Doctor in the loop?	How it reaches you	Straight about the thin evidence?	Bottom line
#1	FormBlends	Yes, physician-supervised, prescription required	Compounded and dispensed by a licensed pharmacy; ~$150–300/mo, DAC ~$80–200/mo	Yes, states the one-study reality outright	Supervised access to the same molecule the gray market ships unwatched
#2	HealthRX (healthrx.com)	Yes, clinician-supervised, prescription required	Pharmacy-dispensed under medical supervision	Same compounded caveat disclosed	Second supervised option; clinical screening applies
#3	Amino Asylum	No	Vial mailed, “research use only”	Seller-issued COA, not independently verified	Budget research-chemical seller; no clinician, no prescription
#4	Sports Technology Labs	No	Vial mailed, “research use only”	Publishes third-party COAs, but no oversight	Better paperwork than the rest; still no doctor, no pharmacy
#5	Biotech Peptides	No	Vial mailed, “research use only”	Seller-issued COA, not independently verified	Research-only catalog; no follow-up
#6	Pure Rawz	No	Vial mailed, “research use only”	Seller-issued COA, not independently verified	Broad catalog, same structural hole
#7	Limitless Life	No	Vial mailed, “research use only”	Seller-issued COA, not independently verified	Biohacker marketing; the underlying facts don’t move

That gap between #2 and #3 is the whole case. Above it, a doctor’s name is on the line. Below it, the seller’s own bottle tells you the responsibility is yours alone.

Above the line: somebody signs for this

#1: FormBlends

FormBlends tops the list for a reason that matters to anyone doing harm reduction seriously: there’s a licensed physician between you and the compound. It’s built on telehealth and a dispensing pharmacy, not a stockroom mailing vials to strangers. A physician looks at your case, writes a prescription if it fits, a licensed pharmacy compounds and dispenses, and somebody checks back with you. Supervised CJC-1295 runs roughly $150 to $300 a month. The DAC version runs roughly $80 to $200. Same molecule a research-chemical site will mail you in a padded envelope with “not for human use” stamped on it, except here somebody with a license decided whether this was even reasonable for you.

That screening earns its keep with this particular peptide, because the risk flags are specific. The one human trial on record flagged sustained IGF-1 elevation [P1], the kind of signal a clinician actually tracks in certain patients. A chemical retailer does none of that. Legally, it can’t. It isn’t selling you a treatment. It’s selling you a lab reagent with a note telling you, in writing, not to put it in your body.

I’ll say the honest part out loud, because burying it would make me no better than the sites I’m criticizing. What a supervised setup adds isn’t proof the drug works. It’s the oversight layer: an evaluation, a prescription, a licensed pharmacy, a follow-up. None of that exists when a warehouse ships a vial. And to its credit, FormBlends doesn’t oversell the science. It tells you plainly that CJC-1295 rests on one small study, carries a real trial-history warning, and isn’t FDA-approved. There’s a tracker app too, for logging doses and symptoms between visits, nothing more. Not a prescription. Not a checkout. The friction of an intake form and a real prescription is slower than clicking “add to cart.” That friction is the safety feature, not an inconvenience somebody forgot to remove.

#2: HealthRX

HealthRX (healthrx.com) lands right behind FormBlends for the same structural reason: a clinician signs off before anything ships, and what arrives is a pharmacy-dispensed compounded medication, not a chemical vial with a disclaimer sticker. The screening and the ongoing supervision are the actual product being sold here. Picking between the two supervised options mostly comes down to logistics, which one is licensed in your state, whose intake process you can actually stand to sit through.

Below the line: the vials with no name on the paperwork

Cross the line and the whole model flips. Everyone from here down is a chemical seller filling an order form, not a clinic seeing a patient. I’m listing them because they’re the exact names people search for, and pretending they don’t exist would just send you to find them with zero context. So here’s the context, straight.

These outfits sell CJC-1295 stamped “for research use only” or “not for human consumption.” Read that as load-bearing, not fine print. It’s the entire legal foundation the sale rests on. The moment a product gets pitched for a person to inject, it becomes an unapproved new drug, and dodging exactly that crossing is what the “research” label was written to do. Translated for you: injecting their CJC-1295 is use no regulator has cleared, nobody independently checked the vial for identity, strength, or purity, and if it turns out mislabeled or contaminated, there’s no recall authority and no one on the hook. This isn’t theoretical. 2026 reporting found gray-market injectable peptides carrying impurities including bacteria or heavy metals, immune reactions ranging from mild to life-threatening, and two women critically ill after receiving FDA-flagged peptides at a 2025 event [P4].

#3: Amino Asylum. Budget research-chemical and SARM retailer, CJC-1295 in the research-only catalog. Cheap is the pitch and the warning both. No clinician, no prescription, no accountable chain tied to your specific vial. Any certificate it offers is seller-issued, not independent.

#4: Sports Technology Labs. Give it this: it publishes third-party certificates of analysis and lot-linked results on some products, more transparency than most of this tier bothers with. But a clean sample readout isn’t medical oversight. Still a chemical retailer. No clinician, no prescription, no accountable dispensing.

#5: Biotech Peptides. Research-chemical supplier, research-only catalog, CJC-1295 included. No clinical oversight, no prescription, no follow-up. The caveat covering this whole tier applies without exception.

#6: Pure Rawz. CJC-1295 sold alongside other research peptides, SARMs, nootropics, all under research-use labeling. Bigger catalog, same hole in the floor. No doctor, no pharmacy, human use unapproved, purity resting entirely on trusting a stranger.

#7: Limitless Life. Markets hard to the biohacker crowd, which makes CJC-1295 feel like a supplement instead of the unapproved research chemical it actually is. Friendlier copy changes nothing about the regulatory status or the missing human data.

I’m not ranking these five on product quality, because neither of us can verify it. Without independent, batch-level testing tied to your specific vial, there’s no way to know which one ships cleaner. That’s exactly why a supervised model sits above all of them, not because I like the paperwork, but because paperwork is the only thing that’s checkable.

The one thing that holds: what the science actually says

Here’s where I stop being your advocate and start being your fact-checker. Going the supervised route doesn’t make CJC-1295 proven. It’s still thin, and I owe you the real record.

The human file is one study. Teichman and colleagues, Journal of Clinical Endocrinology and Metabolism, 2006 [P1]. A single subcutaneous dose of CJC-1295 with DAC raised mean growth hormone 2- to 10-fold for six days or more, and IGF-1 1.5- to 3-fold for nine to eleven days. Repeat dosing held IGF-1 above baseline up to 28 days. Estimated half-life ran about 5.8 to 8.1 days. Relatively well tolerated at the doses studied [P1]. That’s proof the mechanism fires. It’s not proof of an outcome. No muscle measured, no fat measured, no recovery measured. The non-DAC version, sold as modified GRF 1-29 with a half-life near thirty minutes, has even less human data behind it, since this was the trial for the DAC form.

The safety file has a death in it. CJC-1295 with DAC reached Phase II under the name DAC:GRF. ConjuChem’s largest trial, 192 people with HIV-related visceral fat, got halted in July 2006 after a participant died following his eleventh weekly injection [P2]. The fair account: the death was a fatal heart attack, the attending physician judged it most likely caused by pre-existing, asymptomatic coronary artery disease unrelated to CJC-1295, and a competing GRF drug’s trial was allowed to keep going [P3][P2]. That’s not proof the compound killed anyone. But the trial stopped, the program was abandoned, and the drug was never approved. Any source that leaves that out is telling you half the story. Research-chemical sellers shipping it to your door never mention it.

No proven muscle or fat-loss effect. Nobody has run a trial measuring lean mass, fat mass, or body composition on CJC-1295 against placebo. The benefit lists floating around online are inferences drawn from the hormone numbers, not actual findings.

The call

CJC-1295 has no FDA approval. The only route to it runs through compounding, on regulatory footing that’s still unsettled, and it’s banned outright in sanctioned sport. If you’re going to pursue it anyway, the only decision that matters is who’s accountable for the vial in your hand, a licensed clinician and pharmacy, or a shipping label that tells you, in writing, this was never meant for you to use.

Questions people keep asking me

Is buying CJC-1295 from a research-chemical site illegal? The sellers stay on the right side of the law by labeling it “research use only,” which keeps the product filed as a lab chemical, not a drug. What’s unapproved is the human use you actually have in mind. CJC-1295 isn’t FDA-approved, and its compounding status is unsettled. April 2026 reporting placed peptides including CJC-1295 in the FDA’s Category 2, which is not a clear green light for routine compounding [P4].

I’m a tested athlete. Does the “research use” label protect me? No, and this is the trap. CJC-1295 is named outright under section S2.2.4 of the WADA 2026 Prohibited List, a growth-hormone-releasing factor banned at all times, in and out of competition [P5]. A sticker doesn’t override a prohibited-substance list. Treat that as a hard stop and go check the current list yourself.

Does going through a doctor make CJC-1295 safe or proven? No. Supervision doesn’t erase the thin evidence or the trial history, and I’m not going to pretend otherwise. What it adds is a licensed clinician and a licensed pharmacy standing in a transaction that would otherwise have neither. The compound is still one small study deep. Still not FDA-approved. The supervised path buys you accountability, not a verdict that the peptide works.

What is CJC-1295 and what does it actually do in the body?

CJC-1295 is a synthetic peptide built to mimic growth hormone-releasing hormone, signaling the pituitary gland to make and release more growth hormone. ConjuChem Biotechnologies developed it originally for clinical research. People chase it now for fat loss, muscle gain, recovery. The human trial evidence is thin and old, so what actually happens to you will vary a lot from what happens to the next person.

What are the side effects people actually report?

Water retention, joint discomfort, tingling or numbness in the hands, flushing at the injection site. Some people get hungrier. Because it raises growth hormone, the longer-term worries include effects on insulin sensitivity and, theoretically, stimulating cell growth that’s already abnormal. Without a clinician watching, you have no early warning system for any of it.

Is CJC-1295 legal to buy and use?

In the US, it’s not FDA-approved for any medical use, so selling it as a drug or supplement for human use isn’t legal. Compounding pharmacies working under physician oversight operate in a different, tightly controlled lane. Most other countries treat it the same or stricter. Buy it from a research-chemical or gray-market site and you’re outside any legal or medical safety net, full stop.

How do I find someone legitimate if I want a doctor actually involved?

Start with a physician, not a shopping cart. A doctor can order labs, check whether your growth hormone axis actually needs anything, and, if it’s warranted, work with a licensed compounding pharmacy. FormBlends runs a physician-supervised compounding model, which means accountability sits at every step. It costs more than a gray-market vial. What you get back is a real prescription, real purity testing, and somebody medically on the hook if it goes wrong.

References

1. Single-dose CJC-1295 with DAC raised growth hormone 2- to 10-fold for 6+ days and IGF-1 1.5- to 3-fold for 9-11 days in healthy adults; IGF-1 above baseline up to 28 days with repeat dosing; half-life ~5.8 to 8.1 days; relatively well tolerated. Teichman SL, et al. Journal of Clinical Endocrinology and Metabolism, 2006. https://pubmed.ncbi.nlm.nih.gov/16352683/
2. ConjuChem’s Phase II CJC-1295 (DAC:GRF) study in 192 people with HIV-related visceral fat was halted in July 2006 after a participant died following his eleventh weekly injection; a competing GRF drug’s trial was allowed to continue. aidsmap, July 2006.
3. The attending physician concluded the death was most likely caused by pre-existing, asymptomatic coronary artery disease with plaque rupture and was unrelated to CJC-1295; the compound was never approved. CJC-1295 development-history summary.
4. Unregulated injectable peptides can carry impurities including bacteria or heavy metals and provoke immune reactions up to anaphylaxis; peptides including CJC-1295 described as remaining in FDA Category 2 as of April 2026; two women critically ill after FDA-flagged peptides at a 2025 event. ProPublica, April 2026.
5. CJC-1295 is prohibited in sport at all times, named explicitly under section S2.2.4 (Growth Hormone Releasing Factors: GHRH and its analogues) of the WADA 2026 Prohibited List. World Anti-Doping Agency, 2026. https://www.wada-ama.org/en/prohibited-list